Barchart.com's Chart Of The Day - Denali Therapeutics - All Time High
After big IPO, Alzheimer's, Parkinson's, ALS drug developer Denali (NASDAQ: DNLI) climbs after market opening - San Francisco Business Times
Denali | Home
Citigroup Initiates Coverage of Denali Therapeutics (DNLI) with Buy Recommendation | Nasdaq
As Denali Therapeutics Inc.'s (NASDAQ:DNLI)) market cap dropped by US$236m, insiders who sold US$6.0m worth of stock were able to offset their losses | Nasdaq
Denali therapeutics hi-res stock photography and images - Alamy
Denali Therapeutics - Company Profile - Tracxn
IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE JOHN SOLAK, derivatively on behalf of DENALI THERAPEUTICS, INC., Plaintiffs,
10 Strong Buy Stocks With up to 243% Upside, According to Top Analysts